UPDATE: Imperial Capital Initiates Coverage on Nutraceutical International Corporation with Outperform Rating, $32 PT as Attractive Pure-Play

In a report published Wednesday, Imperial Capital analyst Mitchell B. Pinheiro initiated coverage on Nutraceutical International Corporation NUTR with an Outperform rating and $32.00 price target. In the report, Imperial Capital noted, “We are initiating coverage of Nutraceutical International Corporation (NUTR) with an Outperform rating and one-year price target of $32 per share, roughly 23% above the recent share price. NURT is an integrated manufacturer, marketer, distributor, and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. We believe NUTR offers investors attractive exposure to the broader health and wellness category at a reasonable price.” Nutraceutical International Corporation closed on Tuesday at $25.93.